Incyte Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Due to inventory build up in the first quarter 2026, Incyte's inventory turnover ratio sequentially decreased to 4.21 in the first quarter 2026, unsurprisingly, as the Incyte markets continue to deteriorate, and INCY's faces growing challenges to bring down its inventories. Incyte's average inventory processing period in the Mar 31 2026 quarter, has increased to 87 days, from 81 days, in the Dec 31 2025 quarter.

Within Healthcare sector 89 other companies have achieved higher inventory turnover ratio. While in terms of ranking among all other companies, the company has moved form 192 in the fourth quarter 2025, to 792.

INCY Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Incyte Corporation Market Share?

What is Inventory Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Inventory Turnover▼

None ▼

Inventory Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

INCY Inventory Turnover Ratio	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter	(Jun 30 2025) II. Quarter	(Mar 31 2025) I. Quarter
Y / Y Inventory Growth	80.73 %	71.66 %	18.46 %	-17.16 %	0.52 %
Y / Y Cost of Sales Growth	42.81 %	36.94 %	15.13 %	2.78 %	20.07 %
Inventory Turnover Ratio (TTM)	4.21	4.48	4.69	4.72	4.41
INCY's Total Ranking	# 792	# 192	# 196	# 149	# 149
Average inventory processing period	87	81	78	77	83
Seq. Inventory Growth	14.41 %	21.11 %	0.03 %	30.4 %	8.67 %
Seq. Cost of Sales Growth	-13.74 %	22.4 %	25.69 %	7.62 %	-17.29 %

Inventory Turnover Ratio Company Ranking
Within:	No.
Medical Laboratories Industry	# 10
Healthcare Sector	# 90
Overall Market	# 792

Inventory Turnover Ratio Statistics
High	Average	Low
21.53	9.02	1.4
(Sep 30 2017)		(Mar 31 2013)

INCY Company Profile >> Back to INCY Efficiency Comparisons >> Compare INCY Inventory Turnover Ratio to its Competitors

Financial Statements
Incyte's Inventories	$ 116 Millions	Visit INCY's Balance sheet
Incyte's Cost of Revenues TTM	$ 403 Millions	Visit INCY's Income Statement
What are INCY's Sales?		Visit INCY's Sales by Segment

Other Inventory Turnover Ratios
Incyte's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Medical Laboratories Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
INCY's Inventory Turnover Ratio versus Medical Laboratories Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for INCY's Competitors
Inventory Turnover Ratio for INCY's Suppliers
Inventory Turnover Ratio for INCY's Customers

You may also want to know
INCY's Sales Growth Rates	INCY's Pe Price to earnings ratio	INCY's Receivables Turnover Ratio	INCY's Stock Quote
INCY's Net Income Growth Rates	INCY's Ps Price to Sales ratio	INCY's Sales per Employee	INCY's Asset Turnover Ratio
INCY's Net Margin	INCY's Pb Price to Book ratio	INCY's Financial Strength Ratios	INCY's Dividend Payout Ratio

Companies with similar Inventory Turnover Ratio for the quarter ending Mar 31 2026, within Healthcare Sector	Inventory Turnover Ratio	Cost of revenues at quarter ending Mar 31 2026	Inventories at quarter ending Mar 31 2026
Sotera Health Company	9.58	$ 531.000 Millions	$ 55 Millions
Warby Parker Inc	9.23	$ 415.000 Millions	$ 45 Millions
Tarsus Pharmaceuticals Inc	9.09	$ 37.864 Millions	$ 4 Millions
National Vision Holdings Inc	8.90	$ 833.415 Millions	$ 94 Millions
Myriad Genetics Inc	8.35	$ 248.000 Millions	$ 30 Millions
Pulse Biosciences Inc	8.08	$ 0.909 Millions	$ 0 Millions
Castle Biosciences Inc	7.97	$ 75.178 Millions	$ 9 Millions
Moderna Inc	7.96	$ 1,733.000 Millions	$ 218 Millions
Carlsmed Inc	7.95	$ 12.557 Millions	$ 2 Millions
Inogen Inc	7.80	$ 195.741 Millions	$ 25 Millions
Cardiff Lexington Corporation	7.70	$ 4.159 Millions	$ 1 Millions
Novavax inc	7.67	$ 89.620 Millions	$ 12 Millions
Prophase Labs Inc	7.64	$ 2.361 Millions	$ 0 Millions
Bellevue Life Sciences Acquisition Corp	7.62	$ 1.986 Millions	$ 0 Millions
Lifemd Inc	7.60	$ 24.000 Millions	$ 3 Millions
Charles River Laboratories International inc	7.56	$ 2,346.239 Millions	$ 310 Millions
Adaptive Biotechnologies Corporation	7.43	$ 73.088 Millions	$ 10 Millions
Puma Biotechnology Inc	7.19	$ 58.025 Millions	$ 8 Millions
Fonar Corporation	7.06	$ 19.685 Millions	$ 3 Millions
Carlisle Companies Incorporated	6.71	$ 3,206.100 Millions	$ 478 Millions
Hims and Hers Health Inc	6.58	$ 670.000 Millions	$ 102 Millions
Vanda Pharmaceuticals Inc	6.54	$ 12.682 Millions	$ 2 Millions
Twist Bioscience Corporation	6.50	$ 196.251 Millions	$ 30 Millions
Phathom Pharmaceuticals Inc	6.48	$ 30.871 Millions	$ 5 Millions
Precision Optics Corporation Inc	6.47	$ 24.932 Millions	$ 4 Millions
Nuo Therapeutics Inc	6.42	$ 1.331 Millions	$ 0 Millions
Collegium Pharmaceutical Inc	6.41	$ 256.071 Millions	$ 40 Millions
Veracyte Inc	6.05	$ 132.000 Millions	$ 22 Millions
Kewaunee Scientific Corporation	5.98	$ 200.155 Millions	$ 33 Millions
Adm Tronics Unlimited Inc	5.93	$ 1.992 Millions	$ 0 Millions

Date modified: 2026-08-29T17:15:55+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.